Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
John B Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E Schmidt, Eduard Montanya, Jason H Brett, Marcin Zychma, Lawrence BlondeVolume:
374
Year:
2009
Language:
english
DOI:
10.1016/s0140-6736(09)60659-0
File:
PDF, 244 KB
english, 2009